ArticleExperimental hematology2016

Transient potential receptor melastatin-2 (Trpm2) does not influence murine MLL-AF9-driven AML leukemogenesis or in vitro response to chemotherapy.

Jessica N Haladyna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.